Fundraising FoxHealthtech Startups
18,759 companies tagged Healthtech, with their investors and founders.
Linus Health builds a digital cognitive assessment platform that applies AI to established cognitive tests to detect early signs of cognitive impairment and guide clinical action. It serves healthcare providers across care settings and life science researchers running clinical trials, in the brain health and cognitive care field.
0 investors
0 investors
LIPAC Oncology is a pharmaceutical company developing chemotherapy treatments based on LiPax, a neoliposomal platform for local, targeted delivery of paclitaxel to treat intracavitary carcinomas. Its lead program targets non-muscle invasive bladder cancer, with additional indications in thoracic, upper tract urothelial, peritoneal, and ovarian cancers.
0 investors
Lipella Pharmaceuticals was a clinical-stage biotechnology company that developed therapies using a proprietary liposomal drug delivery platform, advancing candidates such as LP-10 and LP-310 through FDA-authorized Phase 2 trials in indications including oral lichen planus and hemorrhagic cystitis. The company ceased research and development activities in 2026 after a court-approved sale of its drug programs and intellectual property to XRAIY LLC, and the site now serves as a historical corporate archive.
0 investors
Lirio combines behavioral science and artificial intelligence to drive positive behavior change. The company operates a cloud-based AI platform designed to optimize outcomes through behavioral science principles.
0 investors
Lirum Therapeutics is a biopharmaceutical company that acquires, develops, and commercializes novel drug candidates for the treatment of difficult-to-treat, debilitating diseases. It was created by the former management team of Stemline Therapeutics.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Lixte develops cancer therapies, focusing on precision oncology and clinical drug development. The company works on advancing innovative treatments in the oncology field.
0 investors
0 investors
0 investors
Lodestone Biomedical develops biosensing and monitoring tools for the tumor microenvironment in preclinical cancer research models, enabling detection of immune response during early-stage drug discovery. Its research-use-only products and services serve drug development researchers conducting preclinical studies.
0 investors